Mimedx Group, Inc · NASDAQ:MDXG
Mimedx — Cantor Global Healthcare Conference 2025
10 slides from Mimedx's conference presentation, Sep 3, 2025
Slide 1: Cantor Global Healthcare Conference Investor Presentation
Cantor Global Healthcare Conference September 3, 2025 Investor Presentation
Slide 2: Disclaimer & Cautionary Statements
Disclaimer & Cautionary Statements This presentation and our earnings call includes forward-looking statements. Forward-looking statements are subject to risks and uncertainties, and the Company cautions investors against placing undue reliance on such statements. Actual results may differ materiall
Slide 3: A Pioneer and Leader Focused on Helping Humans Heal
A Pioneer and Leader Focused on Helping Humans Heal Cantor Global Healthcare Conference – September 2025 3 Over a decade of experience helping clinicians manage chronic and other hard-to-heal wounds Leading the industry with innovative products and robust supporting clinical data Poised to capitaliz
Slide 4: Addressing a Large and Unmet Need for Healing Solutions
Addressing a Large and Unmet Need for Healing Solutions Cantor Global Healthcare Conference – September 2025 4 Favorable Demographic Trends Increasing Clinical Evidence Expanding Potential For Products 1) Sen CK. Human Wound and Its Burden: Updated 2022 Compendium of Estimates. Adv Wound Care (New R
Slide 5: Expansive Donor Network & IP Power Our Product Offering
Expansive Donor Network & IP Power Our Product Offering 5Cantor Global Healthcare Conference – September 2025 National Network of Birthing Center Partners Ample Placental Supply and Manufacturing Capabilities to Support Continued Growth and Industry Demand Expectant Mothers Introduced to Donation Pr
Slide 6: The Patient Journey in Wound Care
The Patient Journey in Wound Care 6Cantor Global Healthcare Conference – September 2025 Private Office Home Health Mobile Health Nursing Facility Assisted Living Facility Wound Care Clinic Hospital Outpatient Hospital Inpatient …and other care settings Mohs surgery Burn/Trauma DFU VLU Limb Salvage D
Slide 7: Surgical Studies Underway Highlight Product Versatility
Surgical Studies Underway Highlight Product Versatility 7Cantor Global Healthcare Conference – September 2025 Published May 2025 Journal of Drugs in Dermatology Manuscript Pending RCT Enrollment Underway RCT Enrollment Underway Generating Clinical Data in Numerous Surgical Disciplines Incorporating
Slide 8: Large Wound Care Business with Growing Surgical Footprint
Large Wound Care Business with Growing Surgical Footprint 8Cantor Global Healthcare Conference – September 2025 $0 $50,000 $100,000 $150,000 $200,000 $250,000 $0 00 s LTM Surgical Performance LTM @ Q2:24 LTM @ Q2:25 $0 $50,000 $100,000 $150,000 $200,000 $250,000 $0 00 s LTM Wound Performance LTM @ Q
Slide 9: Strategic Priorities Position Us to Win in 2025 & Beyond
Strategic Priorities Position Us to Win in 2025 & Beyond Investor Presentation – August 2025 9 Innovate & Diversify Product Portfolio to Maximize Growth Develop & Deploy Programs to Expand Surgical Footprint Enhance Customer Intimacy Enrollment continues for EPIEFFECT RCT with plans for interim repo
Slide 10: Experienced, Skillful Leadership Team Executing Strategy
Experienced, Skillful Leadership Team Executing Strategy Investor Presentation – August 2025 Prior Roles Include: Management Team with Track Record of Success in MedTech Joe Capper Chief Executive Officer Doug Rice Chief Financial Officer Butch Hulse Chief Administrative Officer & General Counsel Ki
MiMedx Group — Cantor Global Healthcare Conference 2025 on 6ix